You just read:

Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy

News provided by

Janssen Biotech, Inc.

Dec 21, 2017, 16:00 EST